Navigation Links
BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman
Date:10/20/2009

the board of Directors at Merck & Co., Inc. from 1997 to 2002 and is a current board member for Millipore Corporation and Alnylam Pharmaceuticals. Dr. Scolnick holds an A.B. from Harvard College and an M.D. from Harvard University Medical School.

Dr. David Holtzman is the Andrew B. and Gretchen P. Jones Professor and Chairman of Neurology, Professor of Developmental Biology, Associate Director of the Alzheimer's Disease Research Center, and a member of the Hope Center for Neurological Disorders at Washington University School of Medicine. His research focuses on understanding basic mechanisms underlying acute and chronic cell dysfunction in the CNS, particularly how mechanisms may relate to Alzheimer's disease and injury to the developing brain. Prior to Washington University, Dr. Holtzman established the Memory and Cognitive Disorders Clinic at UCSF. Over the course of his career Dr. Holtzman has been recognized with the Paul Beeson Physician Faculty Scholar Award in Aging Research, the Potamkin Prize from the American Academy of Neurology for research on Alzheimer's, election to the American Society for Clinical Investigation, recipient of a MERIT award from the NIA, the MetLife award on Alzheimer's disease and election to the Institute of Medicine of the National Academy of Sciences. Dr. Holtzman holds a B.S. and M.D. from Northwestern University.

About BrainCells Inc.

BrainCells Inc. (BCI) is a drug discovery and development company leading the scientific research of neurogenesis by applying its robust and proprietary platform technology to identify novel pathways for new therapeutics to treat various central nervous system (CNS) diseases. Neurogenesis is the process by which endogenous stem cells in the adult human brain produce new brain tissue, including neurons. With its predictive screening platform, BCI can direct the selection and development of neurogenic compounds, increasing the opportunity for successful clinical t
'/>"/>

SOURCE BrainCells Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety
2. Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression
3. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
4. Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors
5. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
6. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
7. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
8. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
9. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
10. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
11. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... ATLANTA , Jan. 23, 2015 More than a ... a quarter of those with private insurance, filled a prescription ... to a report in this week,s Morbidity and Mortality Weekly ... health care providers to treat moderate to severe pain.  They ...
(Date:1/23/2015)... 2015  HyGreen, Inc., a leader in hand hygiene monitoring, ... Medical, a subsidiary of Ascendis Health Limited, in ... year, hundreds of millions of patients around the world ... transmitted from patient to patient via the unwashed hands ...
(Date:1/23/2015)... Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities & ... for shareholders detailing why a "YES" vote to increase the ... As we reflect upon the 2014 fiscal year ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... More than 60 medical technology manufacturers from across the ... technologies at AdvaMed 2011: The MedTech Conference ... transfer offices will make 9-minute company presentations ... and venture capital investors, and other strategic partners at ...
... BLUE BELL, Pa., Sept. 27, 2011 Inovio Pharmaceuticals, ... in the development of synthetic immunogens against cancers and ... a Cooperative Research and Development Agreement (CRADA) with the ... Technology Directorate Plum Island Animal Disease Center. This collaboration ...
Cached Medicine Technology:Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 2Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 3Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 4Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 5Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 2Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 3Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 4
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in ... Player Health Alliance (PPHA). The PPHA's passion for others' ... including NFL greats, treated for obstructive sleep apnea (OSA) has ... the cause in the valley. The most recent plans for ...
(Date:1/22/2015)... 23, 2015 AngelWeddingDress, the premier women’s ... maternity wedding dresses. View website of AngelWeddingDress.com ... for maternity wedding dresses online for a bridal party. ... high quality for them. Its maternity wedding dresses are ...
(Date:1/22/2015)... January 22, 2015 Autocarinsurancebest.com has released a ... a commercial auto insurance policy . , Auto insurance ... vehicles. It is no longer necessary to call an agent ... now available online on a single website: http://autocarinsurancebest.com/ . ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the American ... effort to further promote visibility and adoption of the top ... AMA journals available via its subscription services, EBSCO will now ... , Long known as both a subscription agency and ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... determined that green onions likely caused a recent outbreak ... 500 people and killed three.//, ,Bill Zavertnik, Chi-Chi's ... officials confirmed that Chi-Chi's employees were not the source ... have done to prevent the outbreak and that it ...
... you were when you heard about the World Trade Center ... forget. But why? A new study finds lasting memories are ... protein kinase C.// ,Researchers from Wake Forest University Baptist ... of the Society of Neuroscience in New Orleans. Researchers say ...
... A simple vitamin supplement could significantly reduce the number of ... finds a new study.// ,AMD, which is caused by ... of blindness among older people. A couple of years ago, ... of the antioxidant vitamins C, E, and beta carotene, along ...
... see it as a promising alternative treatment for breast ... ,Thousands of women have already sought out the therapy, ... after breast cancer is diagnosed, instead of the six ... its long-term benefits remain unproven, some experts caution.,That's why ...
... significant role in the development of colon cancer, find ... Proceedings of the National Academy of Sciences.,// ,Research ... of cancer. Most of these studies link the condition ... specific genes. In this study, investigators from Vanderbilt Institute ...
... before and after knee replacement surgery significantly reduces pain ... Center in Chicago studied 70 patients who were undergoing ... assigned to receive 50 milligrams of an oral NSAID ... 50 milligrams each day for five days after surgery, ...
Cached Medicine News:Health News:Partial-Breast Irradiation an Unproven Therapy 2
Plastic Citrate Tube, .109M / 3.2%...
Inquire...
... EDTA K2 or EDTA K3 tubes. ... therefore blocks the coagulation cascade. Erythrocytes, ... anticoagulated blood sample are stable for ... are for the examination of whole ...
... is a ubiquitous enzyme that catalyzes ... is also the specific protein that ... immunofluorescence (EMA) tests (Bio-Rad catalog number ... serologic tests are highly sensitive and ...
Medicine Products: